![Toru Seo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Toru Seo
Fondateur chez HISHOH Biopharma Co., Ltd.
Postes actifs de Toru Seo
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cellusion Inc.
![]() Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Cellusion Inc. is a Japanese company that focuses on regenerating corneal endothelium using IPS cells to treat bullous keratopathy. The company is based in Tokyo, Japan. The company was founded in 2015 by Shigeto Shimmura, Kazuo Tsubota, Shin Hatou. | Directeur/Membre du Conseil | - | - |
HISHOH Biopharma Co., Ltd.
![]() HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services HISHOH Biopharma Co., Ltd. is a Japanese company that develops allergen immunotherapy. The company was founded in 2021 by Toru Seo and Naoki Sakurai. Naoki Sakurai has been the CEO since 2021. | Fondateur | 12/04/2021 | - |
Corporate Officer/Principal | 12/04/2021 | - |
Historique de carrière de Toru Seo
Formation de Toru Seo
Wake Forest University | Doctorate Degree |
Statistiques
Internationale
Japon | 3 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Doctorate Degree | 1 |
Founder | 1 |
Sectorielle
Commercial Services | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Cellusion Inc.
![]() Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Cellusion Inc. is a Japanese company that focuses on regenerating corneal endothelium using IPS cells to treat bullous keratopathy. The company is based in Tokyo, Japan. The company was founded in 2015 by Shigeto Shimmura, Kazuo Tsubota, Shin Hatou. | Commercial Services |
HISHOH Biopharma Co., Ltd.
![]() HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services HISHOH Biopharma Co., Ltd. is a Japanese company that develops allergen immunotherapy. The company was founded in 2021 by Toru Seo and Naoki Sakurai. Naoki Sakurai has been the CEO since 2021. | Commercial Services |